Literature DB >> 2659592

Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro.

J O Kokkonen1, P T Kovanen.   

Abstract

Secretory granules exocytosed from rat serosal mast cells bind low density lipoprotein (LDL), and on being phagocytosed by macrophages, carry the bound LDL into these cells (Kokkonen, J. O., and Kovanen, P. T. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 2287-2291). The binding of LDL to the granules is mediated through interactions between the apolipoprotein B (apoB) component of LDL and the heparin proteoglycan component of the granules. Here we report how degradation of apoB by the neutral proteases of the granules affects the granule-mediated uptake of LDL by cultured mouse macrophages. During incubation of LDL with proteolytically inactive granules, the rate of uptake of LDL by macrophages increased by 10-fold; whereas during incubation with proteolytically active granules, it increased by 50-fold, the increase in the rate of uptake during proteolysis correlating with the degree of apoB degradation. The 5-fold greater capacity of the proteolytically active granules to enhance the uptake of LDL resulted from their greater capacity to bind LDL, and consequently, to carry it into the macrophages. Electron microscopic analysis of LDL bound to the proteolytically active granules disclosed large spherical particles of fused LDL. The diameters of the granule-bound particles ranged up to 90 nm compared with an average diameter of 22 nm for both native LDL and the LDL bound to proteolytically inactive granules. The results show that granule proteases, by inducing fusion of granule-bound LDL, increase the amount of LDL bound per unit weight of granule heparin proteoglycan. Hence, the two components of mast cell granules, the proteases and the heparin proteoglycan, act in concert to promote the uptake of LDL by macrophages in vitro.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Effect of statins on lipoprotein receptor expression in cell lines from human mast cells and basophils.

Authors:  Shuren Li; Robert Dudczak; Elisabeth Koller; Mehrdad Baghestanian; Minoo Ghannadan; Erich Minar; Christian Pirich; Peter Angelberger; Irene Virgolini; Mei Li; Peter Valent
Journal:  Eur J Clin Pharmacol       Date:  2003-09-10       Impact factor: 2.953

2.  Cloning and characterization of the novel gene for mast cell carboxypeptidase A.

Authors:  D S Reynolds; D S Gurley; K F Austen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

Review 3.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

4.  Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.

Authors:  Jianping Li; Shaiban Jubair; Joseph S Janicki
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

Review 5.  Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.

Authors:  Aina He; Guo-Ping Shi
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Mast cell peptidases (carboxypeptidase A and chymase)-mediated hydrolysis of human angiotensin-(1-12) substrate.

Authors:  Sarfaraz Ahmad; Kendra N Wright; Xuming Sun; Leanne Groban; Carlos M Ferrario
Journal:  Biochem Biophys Res Commun       Date:  2019-08-26       Impact factor: 3.575

7.  Immunological modulation of human cardiac mast cells.

Authors:  G Marone; G de Crescenzo; G Florio; F Granata; V Dente; A Genovese
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

Review 8.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

9.  In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.

Authors:  V V Tertov; V V Kaplun; A N Orekhov
Journal:  Mol Cell Biochem       Date:  1998-06       Impact factor: 3.396

10.  Role of chymase in the local renin-angiotensin system in keloids: inhibition of chymase may be an effective therapeutic approach to treat keloids.

Authors:  Ru Wang; Junjie Chen; Zhenyu Zhang; Ying Cen
Journal:  Drug Des Devel Ther       Date:  2015-08-28       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.